October 12, 2017 / 4:50 PM / in 9 days

BRIEF-Interpace Diagnostics Group updates on warrant exercise agreements ​

Oct 12 (Reuters) - Interpace Diagnostics Group Inc

* Interpace Diagnostics Group says it entered into warrant exercise agreements with certain holders of co’s warrants issued in June 2017​

* Interpace Diagnostics Group - The holders agreed to exercise warrants for 4 million shares of co's common stock at warrant exercise price of $1.25 per share​ Source text: (bit.ly/2yI4028) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below